(2,2'-Bipyridine-kappa2N,N')(1,1-cyclobutanedicarboxylato-kappa2O,O')palladium(II), (1,1-cyclobutanedicarboxylato-kappa2O,O')(1,10-phenanthroline-kappa2N,N')palladium(II) monohydrate and (1,1-cyclobutanedicarboxylato-kappa2O,O')(1,10-phenanthroline-kappa2N,N')palladium(II) dihydrate.
In the three title compounds, [Pd(C(6)H(6)O(4))(C(10)H(8)N(2))], (I), [Pd(C(6)H(6)O(4))(C(12)H(8)N(2))].H(2)O, (IIa), and [Pd(C(6)H(6)O(4))(C(12)H(8)N(2))].2H(2)O, (IIb), respectively, each Pd(II) atom has a similar distorted cis-planar four-coordination geometry, completed by two O atoms of a bidentate 1,1-cyclobutanedicarboxylate anion and two N atoms of either a 2,2'-bipyridine or a 1,10-phenanthroline ligand.
Muranishi
Yasunori
Y
Faculty of Pharmaceutical Sciences, Kinki University, Kowakae 3-4-1, Higashiosaka, Osaka 577-8502, Japan.
Okabe
Nobuo
N